Skip to content
DraconiticResearch
Search Sources API
197,693 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BY 4.0International Journal of Oral Science

A biomimetic nanoparticle coordinates antibacterial and immunomodulatory functions to promote periodontal regeneration

  1. 1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China
  2. 2Biopharmaceutical Research Institute, West China Hospital, Sichuan University, Chengdu, China
  3. 3Stomatological Hospital of Chongqing Medical University & Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences & Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, China

Abstract

Periodontitis is a chronic inflammatory disorder driven by pathogenic microbial communities and an imbalanced host immune response, finally leading to progressive breakdown of periodontal soft and hard tissues. Current treatments primarily target infection but often fail to resolve inflammation or support subsequent tissue repair. Hence, we developed NMm@MINO, a biomimetic nanoparticle constructed by coating minocycline-loaded gelatin nanoparticles with a hybrid neutrophil-macrophage membrane. NMm@MINO formed a stable core-shell structure with a hydrodynamic diameter of (261.53 ± 11.59) nm and a membrane shell thickness of ~21 nm, maintaining colloidal stability for 30 days. Minocycline release was protease-responsive, with ~50% payload released within 2 h under gelatinase exposure and reaching equilibrium at ~8 h. In vitro, NMm@MINO achieved > 99% killing efficiency against Porphyromonas gingivalis and Staphylococcus aureus. Simultaneously, NMm@MINO reprogrammed polarization by downregulating M1-associated transcripts (Nos2, Tnf, Il1b, and Cd86) and upregulating M2-associated markers (Mrc1, Arg1, and Tgfb1), corroborated by decreased iNOS and increased CD206 immunofluorescence. NMm@MINO further enhanced osteogenesis (upregulating Alpl, Spp1, Runx2), suppressed RANKL-induced osteoclastogenesis (reduced TRAP staining and downregulated Acp5, Tnfrsf11a, Ctsk, Fos, and Mmp9; decreased c-Fos immunofluorescence), and promoted fibroblast migration with increased Collagen I immunofluorescence. In a ligature-induced rat periodontitis model (days 3, 7, and 14), local NMm@MINO reduced inflammation (IL-6/CRP IHC; decreased Il6, Crp, and Il1b), improved collagen remodeling (H&E/Masson; increased Col1a1), and mitigated alveolar bone loss (micro-CT: CEJ-ABC, BV/TV, Tb.N, Tb.Th, and Tb.Sp) while modulating osteoclast/osteogenic markers (TRAP, RANKL/OPG IHC; Acp5, Tnfsf11, Tnfrsf11b, and Runx2). Collectively, NMm@MINO coordinates antibacterial, immunomodulatory, and pro-regenerative actions for periodontitis therapy.

Related

  1. Immunomodulatory effects of high versus low intensity diode laser as adjunct to non-surgical periodontal therapy in periodontitis.
    Amani A Al-Sharani, Wadhah A Al-Hajj, Ahmed A Madfa
    BMC research notesPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCDOAJ
  2. Guided tissue regeneration for severe periodontal disease in dogs: A retrospective study.
    Chul Park, Md Mahbubur Rahman, Kwangil Han +2
    Veterinarni medicinaPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Periodontal Regeneration Using a Mineralizing Hydrogel Loaded with a Synthetic CEMP1-Derived Peptide
    Yu Wang, Guangzhao Guan, Li Mei +3
    BiomoleculesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  4. Development of a Bioactive Carboxymethyl Cellulose (CMC)/Keratin/Platelet‐Rich Fibrin (PRF) Composite Scaffold for Periodontal Regeneration
    Saba Jaffarkhah, Raziyeh Najafloo, Saeedeh Zare Jalise +3
    BioMed Research InternationalPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  5. Polydeoxyribonucleotide (PDRN) in Osteoarthritis: Immunomodulatory and Matrix-Supportive Potential, A2A Receptor-Associated Mechanisms, and Translational Challenges
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{tang2026biomimetic,
  title = {{A biomimetic nanoparticle coordinates antibacterial and immunomodulatory functions to promote periodontal regeneration}},
  author = {Yufei Tang and Junhua Xu and Fang Zheng and Qin Xue and Sze Wing Cheung and Min Sun and Song Zhou and Yao He and Lin Xiang},
  journal = {International Journal of Oral Science},
  year = {2026},
  month = oct,
  doi = {10.1038/s41368-026-00459-y},
  url = {https://doi.org/10.1038/s41368-026-00459-y},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - A biomimetic nanoparticle coordinates antibacterial and immunomodulatory functions to promote periodontal regeneration
AU  - Yufei Tang
AU  - Junhua Xu
AU  - Fang Zheng
AU  - Qin Xue
AU  - Sze Wing Cheung
AU  - Min Sun
AU  - Song Zhou
AU  - Yao He
AU  - Lin Xiang
PY  - 2026
DA  - 2026/10/26
JO  - International Journal of Oral Science
DO  - 10.1038/s41368-026-00459-y
UR  - https://doi.org/10.1038/s41368-026-00459-y
AB  - Periodontitis is a chronic inflammatory disorder driven by pathogenic microbial communities and an imbalanced host immune response, finally leading to progressive breakdown of periodontal soft and hard tissues. Current treatments primarily target infection but often fail to resolve inflammation or support subsequent tissue repair. Hence, we developed NMm@MINO, a biomimetic nanoparticle constructed by coating minocycline-loaded gelatin nanoparticles with a hybrid neutrophil-macrophage membrane. NMm@MINO formed a stable core-shell structure with a hydrodynamic diameter of (261.53 ± 11.59) nm and a membrane shell thickness of ~21 nm, maintaining colloidal stability for 30 days. Minocycline release was protease-responsive, with ~50% payload released within 2 h under gelatinase exposure and reaching equilibrium at ~8 h. In vitro, NMm@MINO achieved > 99% killing efficiency against Porphyromonas gingivalis and Staphylococcus aureus. Simultaneously, NMm@MINO reprogrammed polarization by downregulating M1-associated transcripts (Nos2, Tnf, Il1b, and Cd86) and upregulating M2-associated markers (Mrc1, Arg1, and Tgfb1), corroborated by decreased iNOS and increased CD206 immunofluorescence. NMm@MINO further enhanced osteogenesis (upregulating Alpl, Spp1, Runx2), suppressed RANKL-induced osteoclastogenesis (reduced TRAP staining and downregulated Acp5, Tnfrsf11a, Ctsk, Fos, and Mmp9; decreased c-Fos immunofluorescence), and promoted fibroblast migration with increased Collagen I immunofluorescence. In a ligature-induced rat periodontitis model (days 3, 7, and 14), local NMm@MINO reduced inflammation (IL-6/CRP IHC; decreased Il6, Crp, and Il1b), improved collagen remodeling (H&E/Masson; increased Col1a1), and mitigated alveolar bone loss (micro-CT: CEJ-ABC, BV/TV, Tb.N, Tb.Th, and Tb.Sp) while modulating osteoclast/osteogenic markers (TRAP, RANKL/OPG IHC; Acp5, Tnfsf11, Tnfrsf11b, and Runx2). Collectively, NMm@MINO coordinates antibacterial, immunomodulatory, and pro-regenerative actions for periodontitis therapy.
SN  - 1674-2818
SN  - 2049-3169
ER  -